8-K/A: American Oncology Network Acquires Central Georgia Cancer Care Assets for $13.3 Million

American Oncology Network, Inc. acquired the assets of Central Georgia Cancer Care for $13.3 million, including cash and a promissory note.

Summary

• American Oncology Network (AON) acquired certain clinical and non-clinical assets of Central Georgia Cancer Care (CGCC) on April 1, 2024.
• The total consideration for the acquisition was approximately $13.3 million.
• This included a cash payment of $4.6 million, a $6.4 million promissory note, and approximately $2.3 million for acquired inventories.
• The promissory note requires monthly payments of principal and interest over 60 months, starting May 1, 2024.
• CGCC operates two cancer and blood disorder treatment centers in Macon and Warner Robins, Georgia.
• Audited financial statements for CGCC for the year ended December 31, 2023, and pro forma financial information related to the acquisition are included in the filing.

Sentiment

Score: 5

Explanation: The acquisition is a positive move for AON's growth, but the financial statements of CGCC show a net loss, which tempers the overall sentiment. The use of a promissory note also adds some financial risk.

Positives

• AON has expanded its network by acquiring a well-established cancer care provider in Georgia.
• The acquisition includes both clinical and non-clinical assets, potentially providing a comprehensive integration.
• The financing structure includes a promissory note, which may ease the immediate cash burden on AON.
• The inclusion of audited financial statements provides transparency into CGCC's financial health.

Negatives

• AON has taken on a $6.4 million promissory note, which will require monthly payments over the next five years.
• The acquisition involves a significant cash outlay of $6.9 million.
• CGCC reported a net loss of $1,034,568 for the year ended December 31, 2023.

Risks

• The integration of CGCC's operations into AON may present challenges.
• The promissory note adds to AON's financial obligations.
• CGCC's recent net loss could impact AON's overall financial performance.
• The healthcare industry is subject to regulatory changes and compliance risks.

Future Outlook

The document does not contain specific forward-looking statements or guidance for AON, but it does detail the terms of the acquisition and the financial position of CGCC.

Management Comments

• Todd Schonherz, Chief Executive Officer of American Oncology Network, Inc., signed the report on behalf of the company.

Industry Context

The acquisition reflects a trend of consolidation in the healthcare industry, where larger networks acquire smaller practices to expand their reach and market share. This is particularly common in specialized areas like oncology, where economies of scale and access to resources can be beneficial.

Comparison to Industry Standards

• The acquisition of a multi-location cancer care practice is a common strategy for companies like AON to expand their network, similar to acquisitions by companies like US Oncology and McKesson.
• CGCC's revenue of approximately $102.6 million is within the range of mid-sized oncology practices, but the net loss of $1,034,568 indicates potential operational challenges that AON will need to address.
• The use of a promissory note in the acquisition is a common financing method, similar to deals seen in the healthcare sector, where a mix of cash and debt is often used to structure acquisitions.
• The financial statements of CGCC are audited by McNair, McLemore, Middlebrooks & Co., LLC, a regional accounting firm, which is typical for a company of this size.

Related Party Transactions

• The Company entered into lease agreements with RAM-CGCC, a joint venture, for equipment and location space.

Stakeholder Impact

• Shareholders of AON may see long-term benefits from the acquisition, but will also bear the risk of the debt and integration.
• CGCC employees will now be part of the AON network, which may bring changes to their employment.
• Patients of CGCC will continue to receive care, now under the AON umbrella.
• Suppliers of CGCC may see changes in their contracts and relationships.

Next Steps

• AON will integrate CGCC's operations into its network.
• AON will begin making monthly payments on the $6.4 million promissory note starting May 1, 2024.
• AON will likely work to improve the financial performance of the acquired CGCC locations.

Key Dates

Keywords

acquisition, oncology, cancer care, healthcare, promissory note, financial statements, assets, merger